Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: KEGG:D02011 (
FAD
)
5,530
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A cadmium-hypersensitive mutant of the fission yeast Schizosaccharomyces pombe was found to accumulate abnormally high levels of sulfide. The gene required for normal regulation of sulfide levels, hmt2(+), was cloned by complementation of the cadmium-hypersensitive phenotype of the mutant. Cell fractionation and immunocytochemistry indicated that
HMT2
protein is localized to mitochondria. Sequence analysis revealed homology between
HMT2
and sulfide dehydrogenases from photosynthetic bacteria.
HMT2
protein, produced in and purified from Escherichia coli, was soluble, bound
FAD
, and catalyzed the reduction of quinone (coenzyme Q2) by sulfide.
HMT2
activity was also detected in isolated fission yeast mitochondria. We propose that
HMT2
functions as a sulfide:quinone oxidoreductase. Homologous enzymes may be widespread in higher organisms, as sulfide-oxidizing activities have been described previously in animal mitochondria, and genes of unknown function, but with similarity to hmt2(+), are present in the genomes of flies, worms, rats, mice, and humans.
...
PMID:A fission yeast gene for mitochondrial sulfide oxidation. 1022 84